FibroGen, Inc.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Rory B Riggs. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Rory B Riggs har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CBUS / Cibus, Inc. Director, 10% Owner 14.583.307
US:ITCI / Intra-Cellular Therapies, Inc. Director 0
US:RPRX / Royalty Pharma plc Director 320.099
US:FGEN / FibroGen, Inc. Director 7.800
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Rory B Riggs. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb FGEN / FibroGen, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FGEN / FibroGen, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FGEN / FibroGen, Inc. Insider Trades
Insidersalg FGEN / FibroGen, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FGEN / FibroGen, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2018-03-13 FGEN RIGGS RORY B 5.402 53,0700 216 1.326,7500 286.684 269 37.9700 -278.482 -97,14
2018-03-13 FGEN RIGGS RORY B 4.382 54,9000 175 1.372,5000 240.572
2018-03-13 FGEN RIGGS RORY B 2.618 55,1900 105 1.379,7500 144.487
2018-03-12 FGEN RIGGS RORY B 19.693 54,9800 788 1.374,5000 1.082.721
2018-03-09 FGEN RIGGS RORY B 22.905 55,7500 916 1.393,7500 1.276.954
2017-09-13 FGEN RIGGS RORY B 25.000 51,9200 1.000 1.298,0000 1.298.000
2016-12-16 FGEN RIGGS RORY B 20.000 20,8655 800 521,6375 417.310
2015-09-14 FGEN RIGGS RORY B 25.571 27,5600 1.023 689,0000 704.737
2015-09-11 FGEN RIGGS RORY B 20.000 27,5600 800 689,0000 551.200
2015-09-11 FGEN RIGGS RORY B 4.329 28,1300 173 703,2500 121.775
2015-09-11 FGEN RIGGS RORY B 100 29,5200 4 738,0000 2.952

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FGEN / FibroGen, Inc. Insider Trades
Insiderkøb RPRX / Royalty Pharma plc – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FGEN / FibroGen, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2020-06-18 RPRX RIGGS RORY B 15.000 28,0000 15.000 28,0000 420.000 222 52.8200 372.300 88,64

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RPRX / Royalty Pharma plc Insider Trades
Insidersalg RPRX / Royalty Pharma plc – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FGEN / FibroGen, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-01-04 RPRX RIGGS RORY B 35.702 27,5476 35.702 27,5476 983.504 350 24.2800 -116.659 -11,86
2024-01-03 RPRX RIGGS RORY B 199.098 27,7867 199.098 27,7867 5.532.276
2024-01-02 RPRX RIGGS RORY B 235.200 28,5165 235.200 28,5165 6.707.081
2023-05-22 RPRX RIGGS RORY B 1.750.000 32,8200 1.750.000 32,8200 57.435.000
2023-03-30 RPRX RIGGS RORY B 130.024 36,2575 130.024 36,2575 4.714.345
2023-03-29 RPRX RIGGS RORY B 9.926 36,9500 9.926 36,9500 366.766
2022-12-09 RPRX RIGGS RORY B 19.990 42,0680 19.990 42,0680 840.939
2022-11-17 RPRX RIGGS RORY B 120.000 42,3327 120.000 42,3327 5.079.924
2022-09-15 RPRX RIGGS RORY B 52.025 42,2097 52.025 42,2097 2.195.960
2022-09-14 RPRX RIGGS RORY B 47.975 42,4060 47.975 42,4060 2.034.428
2022-08-09 RPRX RIGGS RORY B 45.000 43,7294 45.000 43,7294 1.967.823
2022-06-29 RPRX RIGGS RORY B 30.000 42,1746 30.000 42,1746 1.265.238
2022-05-20 RPRX RIGGS RORY B 123.696 39,2790 123.696 39,2790 4.858.655
2022-05-19 RPRX RIGGS RORY B 26.304 40,0947 26.304 40,0947 1.054.651
2022-03-29 RPRX RIGGS RORY B 60.000 38,5887 60.000 38,5887 2.315.322
2022-03-21 RPRX RIGGS RORY B 25.545 39,0510 25.545 39,0510 997.558
2022-03-21 RPRX RIGGS RORY B 14.322 39,0510 14.322 39,0510 559.288
2022-03-18 RPRX RIGGS RORY B 46.803 39,3831 46.803 39,3831 1.843.247
2022-03-18 RPRX RIGGS RORY B 26.238 39,3831 26.238 39,3831 1.033.334
2022-03-18 RPRX RIGGS RORY B 56.181 39,7660 56.181 39,7660 2.234.094
2021-12-29 RPRX RIGGS RORY B 75.000 40,0047 75.000 40,0047 3.000.352
2021-12-28 RPRX RIGGS RORY B 47.578 40,2054 47.578 40,2054 1.912.893
2021-12-28 RPRX RIGGS RORY B 26.677 40,2054 26.677 40,2054 1.072.559
2021-12-28 RPRX RIGGS RORY B 35.193 40,2058 35.193 40,2058 1.414.963
2021-11-17 RPRX RIGGS RORY B 62.435 42,3865 62.435 42,3865 2.646.401
2021-11-17 RPRX RIGGS RORY B 69.233 42,3483 69.233 42,3483 2.931.900
2021-11-17 RPRX RIGGS RORY B 38.815 42,3483 38.815 42,3483 1.643.749
2021-11-17 RPRX RIGGS RORY B 31.341 42,3291 31.341 42,3291 1.326.636
2021-11-16 RPRX RIGGS RORY B 12.565 42,0060 12.565 42,0060 527.805
2021-09-29 RPRX RIGGS RORY B 24.648 36,5022 24.648 36,5022 899.706
2021-09-29 RPRX RIGGS RORY B 34.604 36,3144 34.604 36,3144 1.256.623
2021-09-29 RPRX RIGGS RORY B 22.173 36,3144 22.173 36,3144 805.199
2021-09-29 RPRX RIGGS RORY B 7.000 36,6673 7.000 36,6673 256.671
2021-09-28 RPRX RIGGS RORY B 40.000 36,7522 40.000 36,7522 1.470.088
2021-06-29 RPRX RIGGS RORY B 1.200 42,0073 1.200 42,0073 50.409
2021-06-29 RPRX RIGGS RORY B 479.800 41,2556 479.800 41,2556 19.794.437
2021-06-28 RPRX RIGGS RORY B 167.448 42,1102 167.448 42,1102 7.051.269
2021-06-25 RPRX RIGGS RORY B 179.100 42,8057 179.100 42,8057 7.666.501
2021-06-25 RPRX RIGGS RORY B 487.364 42,6940 487.364 42,6940 20.807.519
2021-06-07 RPRX RIGGS RORY B 273.650 45,2600 273.650 45,2600 12.385.399
2020-10-20 RPRX RIGGS RORY B 463.200 42,0000 463.200 42,0000 19.454.400
2002-12-12 RPRX RIGGS RORY B 40.010 41,9816 40.010 41,9816 1.679.684

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RPRX / Royalty Pharma plc Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Rory B Riggs som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-11 2025-06-09 4 CBUS Cibus, Inc.
Class A Common Stock
X - Other 50.000 14.583.307 0,34 0,01 500 145.833
2025-06-11 2025-06-09 4 CBUS Cibus, Inc.
Class A Common Stock
X - Other 4.000.000 14.533.307 37,97 0,00 400 1.453
2025-06-10 2025-06-05 4 CBUS Cibus, Inc.
Class A Common Stock
A - Award 5.714.286 10.533.307 118,58 1,75 10.000.000 18.433.287
2025-04-02 2025-04-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
D - Sale to Issuer -131.512 0 -100,00 132,00 -17.359.584
2025-01-10 2024-12-31 4 CBUS Cibus, Inc.
Class A Common Stock
C - Conversion 1.388.084 4.839.912 40,21
2025-01-10 2024-12-31 4 CBUS Cibus, Inc.
Class B Common Stock
C - Conversion -1.388.084 0 -100,00
2025-01-03 2024-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 215 131.512 0,16 83,52 17.957 10.983.882
2024-10-15 2019-06-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 14.189 131.297 12,12
2024-10-02 2024-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 246 117.108 0,21 73,17 18.000 8.568.792
2024-09-20 2024-09-18 4 CBUS Cibus, Inc.
Class A Common Stock
A - Award 250.000 3.451.828 7,81 4,00 1.000.000 13.807.312
2024-07-02 2024-06-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 262 116.862 0,22 68,49 17.944 8.003.878
2024-06-25 2024-06-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -4.462 116.600 -3,69 75,57 -337.193 8.811.462
2024-06-25 2024-06-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20.000 121.062 19,79 16,86 337.200 2.041.105
2024-06-25 2024-06-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 1.567 101.062 1,57
2024-06-14 2024-06-11 4 CBUS Cibus, Inc.
Class A Common Stock
A - Award 98.040 3.201.828 3,16 10,20 1.000.008 32.658.646
2024-04-02 2024-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 260 99.495 0,26 69,20 17.992 6.885.054
2024-03-22 2024-03-20 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20.000 99.235 25,24 18,56 371.200 1.841.802
2024-02-22 2024-02-20 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
C - Conversion 300.000 320.099 1.492,61
2024-01-04 2024-01-04 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -35.702 20.099 -63,98 27,55 -983.504 553.679
2024-01-04 2024-01-03 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -199.098 55.801 -78,11 27,79 -5.532.276 1.550.526
2024-01-04 2024-01-02 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -235.200 254.899 -47,99 28,52 -6.707.081 7.268.827
2024-01-03 2023-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 251 79.235 0,32 71,62 17.977 5.674.811
2024-01-03 2023-12-29 4 CBUS Cibus, Inc.
Class A Common Stock
C - Conversion 1.500.000 3.103.788 93,53
2024-01-03 2023-12-29 4 CBUS Cibus, Inc.
Class B Common Stock
C - Conversion -1.500.000 1.367.193 -52,32
2024-01-03 2023-12-29 4 CBUS Cibus, Inc.
Class B Common Stock
J - Other 1.505.967 2.867.193 110,63
2023-12-14 2023-12-12 4 CBUS Cibus, Inc.
Class A Common Stock
P - Purchase 517.107 1.622.495 46,78 10,58 5.470.992 17.165.997
2023-12-14 2023-09-27 4 CBUS Cibus, Inc.
Class A Common Stock
J - Other -39.476 1.105.388 -3,45
2023-11-14 2023-11-13 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
C - Conversion 475.590 490.099 3.277,90
2023-10-02 2023-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 345 78.984 0,44 52,09 17.971 4.114.277
2023-07-05 2023-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 279 78.639 0,36 63,32 17.666 4.979.421
2023-06-26 2023-06-23 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
A - Award 7.747 14.509 114,57
2023-06-02 2023-06-01 4 CBUS Cibus, Inc.
Class A Common Stock
P - Purchase 1.000 1.154.464 0,09 31,50 31.500 36.365.616
2023-06-02 2023-05-31 4 CBUS Cibus, Inc.
Class B Common Stock
A - Award 1.505.967 2.888.084 108,96
2023-06-02 2023-05-31 4 CBUS Cibus, Inc.
Class B Common Stock
A - Award 20.891 1.382.117 1,53
2023-06-02 2023-05-31 4 CBUS Cibus, Inc.
Class B Common Stock
A - Award 1.361.226 1.361.226
2023-06-02 2023-05-31 4 CBUS Cibus, Inc.
Class A Common Stock
A - Award 167.992 1.153.464 17,05
2023-06-02 2023-05-31 4 CBUS Cibus, Inc.
Class A Common Stock
A - Award 9.600 985.472 0,98
2023-06-02 2023-05-31 4 CBUS Cibus, Inc.
Class A Common Stock
A - Award 5.401 975.872 0,56
2023-06-02 2023-05-31 4 CBUS Cibus, Inc.
Class A Common Stock
A - Award 118.893 970.471 13,96
2023-06-02 2023-05-31 4 CBUS Cibus, Inc.
Class A Common Stock
A - Award 2.916 851.578 0,34
2023-06-02 2023-05-31 4 CBUS Cibus, Inc.
Class A Common Stock
A - Award 848.662 848.662
2023-05-22 2023-05-22 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -1.750.000 6.762 -99,62 32,82 -57.435.000 221.929
2023-05-12 2023-05-09 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
C - Conversion 300.000 1.756.762 20,59
2023-04-04 2023-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 313 78.360 0,40 54,15 16.949 4.243.194
2023-03-30 2023-03-30 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -130.024 1.456.762 -8,19 36,26 -4.714.345 52.818.548
2023-03-30 2023-03-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -9.926 1.586.786 -0,62 36,95 -366.766 58.631.743
2023-02-17 2023-02-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
C - Conversion 1.500.000 1.596.712 1.551,00
2023-01-03 2022-12-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 321 78.047 0,41 52,92 16.987 4.130.247
2022-12-13 2022-12-09 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -19.990 136.722 -12,76 42,07 -840.939 5.751.621
2022-12-13 2002-12-12 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -40.010 96.712 -29,26 41,98 -1.679.684 4.060.124
2022-11-21 2022-11-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -120.000 156.712 -43,37 42,33 -5.079.924 6.634.042
2022-10-04 2022-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 365 77.726 0,47 46,53 16.983 3.616.591
2022-09-15 2022-09-15 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -52.025 276.712 -15,83 42,21 -2.195.960 11.679.931
2022-09-15 2022-09-14 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -47.975 328.737 -12,74 42,41 -2.034.428 13.940.421
2022-08-11 2022-08-09 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -45.000 376.712 -10,67 43,73 -1.967.823 16.473.390
2022-07-05 2022-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 289 77.361 0,37 57,08 16.496 4.415.766
2022-06-29 2022-06-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -30.000 421.712 -6,64 42,17 -1.265.238 17.785.535
2022-05-23 2022-05-20 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -123.696 451.712 -21,50 39,28 -4.858.655 17.742.796
2022-05-23 2022-05-19 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -26.304 575.408 -4,37 40,09 -1.054.651 23.070.811
2022-04-04 2022-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 257 77.072 0,33 61,19 15.726 4.716.036
2022-03-30 2022-03-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -60.000 601.712 -9,07 38,59 -2.315.322 23.219.284
2022-03-21 2022-03-21 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -14.322 0 -100,00 39,05 -559.288
2022-03-21 2022-03-21 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -25.545 0 -100,00 39,05 -997.558
2022-03-21 2022-03-18 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -56.181 85.187 -39,74 39,77 -2.234.094 3.387.546
2022-03-21 2022-03-18 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -26.238 14.322 -64,69 39,38 -1.033.334 564.045
2022-03-21 2022-03-18 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -46.803 25.545 -64,69 39,38 -1.843.247 1.006.041
2022-03-21 2022-03-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -531.684 141.368 -79,00
2022-03-21 2022-03-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -1.075.178 40.560 -96,36
2022-03-21 2022-03-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -229.626 72.348 -76,04
2022-03-21 2022-03-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other 64.067 661.712 10,72
2022-03-21 2022-03-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other 4.897 597.645 0,83
2022-03-18 2022-03-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -15.736 0 -100,00 61,35 -965.352
2022-03-18 2022-03-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -4.901 15.736 -23,75 60,63 -297.154 954.093
2022-03-18 2022-03-17 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -114.912 20.637 -84,78 60,41 -6.941.570 1.246.634
2022-03-18 2022-03-17 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -26.587 135.549 -16,40 59,99 -1.595.076 8.132.208
2022-03-18 2022-03-16 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -43.848 162.136 -21,29 59,53 -2.610.057 9.651.162
2022-03-18 2022-03-16 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -20.686 205.984 -9,13 58,72 -1.214.771 12.096.266
2022-01-04 2021-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 300 76.815 0,39 52,34 15.702 4.020.497
2021-12-30 2021-12-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -75.000 592.748 -11,23 40,00 -3.000.352 23.712.706
2021-12-30 2021-12-28 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -35.193 673.052 -4,97 40,21 -1.414.963 27.060.594
2021-12-30 2021-12-28 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -26.677 1.115.738 -2,34 40,21 -1.072.559 44.858.693
2021-12-30 2021-12-28 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -47.578 301.974 -13,61 40,21 -1.912.893 12.140.985
2021-12-30 2021-12-28 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -407.400 708.245 -36,52
2021-12-30 2021-12-28 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -707.155 1.142.415 -38,23
2021-12-30 2021-12-28 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -150.997 349.552 -30,17
2021-12-30 2021-12-28 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other 42.138 667.748 6,74
2021-12-30 2021-12-28 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other 3.212 625.610 0,52
2021-11-18 2021-11-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -31.341 1.115.645 -2,73 42,33 -1.326.636 47.224.249
2021-11-18 2021-11-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -38.815 1.849.570 -2,06 42,35 -1.643.749 78.326.145
2021-11-18 2021-11-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -69.233 500.549 -12,15 42,35 -2.931.900 21.197.399
2021-11-18 2021-11-17 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -62.435 622.398 -9,12 42,39 -2.646.401 26.381.273
2021-11-18 2021-11-16 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -612.668 1.146.986 -34,82
2021-11-18 2021-11-16 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -1.028.973 1.888.385 -35,27
2021-11-18 2021-11-16 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -219.710 569.782 -27,83
2021-11-18 2021-11-16 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -12.565 684.833 -1,80 42,01 -527.805 28.767.095
2021-11-18 2021-11-16 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other 61.338 697.398 9,64
2021-11-18 2021-11-16 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other 4.674 636.060 0,74
2021-10-04 2021-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 422 76.515 0,55 37,28 15.732 2.852.479
2021-09-30 2021-09-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -314.886 1.759.654 -15,18
2021-09-30 2021-09-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -7.000 2.074.540 -0,34 36,67 -256.671 76.067.781
2021-09-30 2021-09-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -511.727 2.917.358 -14,92
2021-09-30 2021-09-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -22.173 3.429.085 -0,64 36,31 -805.199 124.525.164
2021-09-30 2021-09-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other -109.814 789.492 -12,21
2021-09-30 2021-09-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -34.604 899.306 -3,71 36,31 -1.256.623 32.657.758
2021-09-30 2021-09-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other 8.641 631.386 1,39
2021-09-30 2021-09-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other 5.299 622.745 0,86
2021-09-30 2021-09-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
J - Other 2.334 617.446 0,38
2021-09-30 2021-09-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -24.648 615.112 -3,85 36,50 -899.706 22.452.941
2021-09-30 2021-09-28 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -40.000 639.760 -5,88 36,75 -1.470.088 23.512.587
2021-09-30 2021-09-10 4 RPRX Royalty Pharma plc
LP interests in RPI US Partners 2019, LP
G - Gift -7.692 534.059 -1,42
2021-07-02 2021-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 385 76.093 0,51 40,82 15.716 3.106.116
2021-06-29 2021-06-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -479.800 3.451.258 -12,21 41,26 -19.794.437 142.383.720
2021-06-29 2021-06-29 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -1.200 3.931.058 -0,03 42,01 -50.409 165.133.133
2021-06-29 2021-06-28 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -167.448 3.932.258 -4,08 42,11 -7.051.269 165.588.171
2021-06-29 2021-06-25 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -487.364 4.099.706 -10,62 42,69 -20.807.519 175.032.848
2021-06-29 2021-06-25 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -179.100 933.910 -16,09 42,81 -7.666.501 39.976.671
2021-06-22 2021-06-21 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2021-06-08 2021-06-07 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale 273.650 2.081.540 15,14 45,26 12.385.399 94.210.500
2021-06-04 2021-05-27 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -13.767 0 -100,00
2021-06-04 2021-05-27 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13.767 75.708 22,23
2021-05-28 2021-05-26 4 FGEN FIBROGEN INC
Stock Option (Right to Buy)
A - Award 7.800 7.800
2021-05-28 2021-05-26 4 FGEN FIBROGEN INC
Common Stock
A - Award 4.700 395.750 1,20
2021-05-11 2021-05-07 4 RPRX Royalty Pharma plc
LP interests in RPI US Partners 2019, LP
C - Conversion -235.519 0 -100,00
2021-05-11 2021-05-07 4 RPRX Royalty Pharma plc
LP interests in RPI US Partners 2019, LP
C - Conversion -67.976 541.751 -11,15
2021-05-11 2021-05-07 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
C - Conversion 2.355.190 2.355.190
2021-05-11 2021-05-07 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
C - Conversion 679.760 679.760
2021-04-02 2021-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 464 61.941 0,75 33,93 15.744 2.101.658
2021-02-26 2020-06-18 4/A RPRX Royalty Pharma plc
Class A Ordinary Shares
C - Conversion 1.113.010 1.113.010
2021-02-26 2020-06-18 4/A RPRX Royalty Pharma plc
Class A Ordinary Shares
C - Conversion 4.587.070 4.587.070
2021-01-05 2020-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 495 61.477 0,81 31,80 15.741 1.954.969
2020-10-23 2020-10-20 4/A RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -463.200 0 -100,00 42,00 -19.454.400
2020-10-22 2020-10-20 4 RPRX Royalty Pharma plc
LP interests in RPI US Partners 2019, LP
C - Conversion -46.320 191.681 -19,46
2020-10-22 2020-10-20 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
S - Sale -463.200 0 -100,00 42,00 -19.454.400
2020-10-22 2020-10-20 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
C - Conversion 463.200 463.200
2020-10-02 2020-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 613 60.982 1,02 25,66 15.730 1.564.798
2020-07-02 2020-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 613 60.369 1,03 25,67 15.736 1.549.672
2020-06-26 2020-06-25 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -14.005 0 -100,00
2020-06-26 2020-06-25 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 14.005 59.756 30,61
2020-06-23 2020-06-18 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
P - Purchase 15.000 15.000 28,00 420.000 420.000
2020-06-23 2020-06-15 4 RPRX Royalty Pharma plc
LP interests in RPI International Holdings 2019, LP
A - Award 119.982 119.982
2020-06-23 2020-06-15 4 RPRX Royalty Pharma plc
LP interests in RPI International Holdings 2019, LP
A - Award 494.485 494.485
2020-06-23 2020-06-15 4 RPRX Royalty Pharma plc
LP interests in RPI US Partners 2019, LP
A - Award 253.889 253.889
2020-06-23 2020-06-15 4 RPRX Royalty Pharma plc
LP interests in RPI US Partners 2019, LP
A - Award 435.267 435.267
2020-06-23 2020-06-15 4 RPRX Royalty Pharma plc
LP interests in RPI US Partners 2019, LP
A - Award 238.001 238.001
2020-06-08 2020-06-04 4 FGEN FIBROGEN INC
Stock Option (Right to Buy)
A - Award 7.800 7.800
2020-06-08 2020-06-04 4 FGEN FIBROGEN INC
Common Stock
A - Award 4.700 391.050 1,22
2020-05-28 2020-05-27 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 13.767 13.767
2020-04-02 2020-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 1.024 45.751 2,29 15,37 15.739 703.193
2020-01-03 2019-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 422 44.727 0,95 34,31 14.479 1.534.583
2019-10-02 2019-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 1.941 44.305 4,58 7,47 14.499 330.958
2019-07-02 2019-06-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 1.117 42.364 2,71 12,98 14.499 549.885
2019-06-26 2019-06-25 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 14.005 14.005
2019-06-07 2019-06-05 4 FGEN FIBROGEN INC
Stock Option (Right to Buy)
A - Award 7.800 7.800
2019-06-07 2019-06-05 4 FGEN FIBROGEN INC
Common Stock
A - Award 4.700 386.350 1,23
2019-04-02 2019-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 1.190 41.247 2,97 12,18 14.494 502.388
2019-01-03 2018-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 1.273 40.057 3,28 11,39 14.499 456.249
2018-10-02 2018-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 668 38.784 1,75 21,70 14.496 841.613
2018-09-28 2018-09-27 4 FGEN FIBROGEN INC
Common Stock
G - Gift -1.250 381.650 -0,33
2018-07-03 2018-06-29 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 820 38.116 2,20 17,67 14.489 673.510
2018-06-20 2018-06-18 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 14.189 14.189
2018-06-07 2018-06-05 4 FGEN FIBROGEN INC
Stock Option (Right to Buy)
A - Award 6.000 6.000
2018-06-07 2018-06-05 4 FGEN FIBROGEN INC
Common Stock
A - Award 3.700 382.900 0,98
2018-04-03 2018-03-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 688 37.296 1,88 21,05 14.482 785.081
2018-03-14 2018-03-13 4 FGEN FIBROGEN INC
Common Stock
S - Sale -2.618 379.200 -0,69 55,19 -144.487 20.928.048
2018-03-14 2018-03-13 4 FGEN FIBROGEN INC
Common Stock
S - Sale -4.382 381.818 -1,13 54,90 -240.572 20.961.808
2018-03-14 2018-03-13 4 FGEN FIBROGEN INC
Common Stock
S - Sale -5.402 386.200 -1,38 53,07 -286.684 20.495.634
2018-03-14 2018-03-12 4 FGEN FIBROGEN INC
Common Stock
S - Sale -19.693 391.602 -4,79 54,98 -1.082.721 21.530.278
2018-03-09 2018-03-09 4 FGEN FIBROGEN INC
Common Stock
S - Sale -22.905 411.295 -5,28 55,75 -1.276.954 22.929.696
2018-02-14 2017-12-15 5 FGEN FIBROGEN INC
Common Stock
G - Gift -1.000 434.200 -0,23
2018-01-03 2017-12-29 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
P - Purchase 1.001 36.608 2,81 14,48 14.494 530.084
2018-01-03 2017-12-29 4/A ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 1.001 36.608 2,81 14,48 14.494 530.084
2017-10-03 2017-09-29 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 918 35.607 2,65
2017-09-15 2017-09-13 4 FGEN FIBROGEN INC
Common Stock
S - Sale -25.000 435.200 -5,43 51,92 -1.298.000 22.595.584
2017-07-05 2017-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 1.167 34.689 3,48
2017-06-29 2017-06-27 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2017-06-09 2017-06-07 4 FGEN FIBROGEN INC
Stock Option (Right to Buy)
A - Award 12.000 12.000
2017-04-04 2017-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 892 33.522 2,73
2017-01-03 2016-12-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 960 32.630 3,03
2016-12-16 2016-12-16 4 FGEN FIBROGEN INC
Common Stock
S - Sale -20.000 460.200 -4,16 20,87 -417.310 9.602.303
2016-10-04 2016-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 951 31.670 3,10
2016-07-05 2016-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 373 30.719 1,23
2016-06-15 2016-06-14 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2016-06-10 2016-06-08 4 FGEN FIBROGEN INC
Stock Option (Right to Buy)
A - Award 12.000 12.000
2016-04-20 2014-02-05 4/A ITCI Intra-Cellular Therapies, Inc.
Common Stock
P - Purchase 14.285 26.091 121,00 17,50 249.988 456.592
2016-04-20 2014-02-05 4/A ITCI Intra-Cellular Therapies, Inc.
Common Stock
P - Purchase 14.286 226.670 6,73 17,50 250.005 3.966.725
2016-04-04 2016-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 382 16.061 2,44
2016-01-05 2015-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 197 15.679 1,27 53,79 10.597 843.373
2015-10-02 2015-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 265 15.482 1,74
2015-09-15 2015-09-14 4 FGEN FIBROGEN INC
Common Stock
S - Sale -25.571 480.200 -5,06 27,56 -704.737 13.234.312
2015-09-15 2015-09-11 4 FGEN FIBROGEN INC
Common Stock
S - Sale -100 505.771 -0,02 29,52 -2.952 14.930.360
2015-09-15 2015-09-11 4 FGEN FIBROGEN INC
Common Stock
S - Sale -4.329 505.871 -0,85 28,13 -121.775 14.230.151
2015-09-15 2015-09-11 4 FGEN FIBROGEN INC
Common Stock
S - Sale -20.000 510.200 -3,77 27,56 -551.200 14.061.112
2015-07-02 2015-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 332 15.217 2,23
2015-06-22 2015-06-16 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2015-06-05 2015-06-03 4 FGEN FIBROGEN INC
Stock Option (Right to Buy)
A - Award 12.000 12.000
2015-04-02 2015-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 444 14.885 3,07
2015-01-05 2014-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 601 14.441 4,34
2014-11-21 2014-11-19 4 FGEN FIBROGEN INC
Series F Convertible Preferred Stock
C - Conversion -50.000 0 -100,00
2014-11-21 2014-11-19 4 FGEN FIBROGEN INC
Series RA Convertible Preferred Stock
C - Conversion -100.000 0 -100,00
2014-11-21 2014-11-19 4 FGEN FIBROGEN INC
Series E Convertible Preferred Stock
C - Conversion -334.074 0 -100,00
2014-11-21 2014-11-19 4 FGEN FIBROGEN INC
Series B Convertible Preferred Stock
C - Conversion -150.177 0 -100,00
2014-11-21 2014-11-19 4 FGEN FIBROGEN INC
Series A Convertible Preferred Stock
C - Conversion -225.000 0 -100,00
2014-11-21 2014-11-19 4 FGEN FIBROGEN INC
Common Stock
C - Conversion 233.699 605.713 62,82
2014-11-21 2014-11-19 4 FGEN FIBROGEN INC
Common Stock
C - Conversion 110.000 530.200 26,18
2014-11-17 2014-11-13 4 FGEN FIBROGEN INC
Stock Option (Right to Buy)
A - Award 12.000 12.000
2014-11-13 3 FGEN FIBROGEN INC
Common Stock
1.212.414
2014-11-13 3 FGEN FIBROGEN INC
Common Stock
1.164.228
2014-11-13 3 FGEN FIBROGEN INC
Common Stock
1.212.414
2014-11-13 3 FGEN FIBROGEN INC
Common Stock
1.164.228
2014-10-02 2014-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 774 13.840 5,92
2014-07-02 2014-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2014-07-02 2014-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 1.260 13.066 10,67
2014-03-24 2014-03-21 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2014-02-05 2014-02-05 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
P - Purchase 28.571 240.955 13,45 17,50 499.992 4.216.712
2014-01-14 3 ITCI Intra-Cellular Therapies, Inc.
Common Stock
11.806
2014-01-14 3 ITCI Intra-Cellular Therapies, Inc.
Common Stock
212.384
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)